An Overview of Current Recommendations and Options for the Management of Cancer Pain : A Comprehensive Review
It is estimated that one-third of oncologic patients in the USA do not receive analgesia proportional to or adequate for the intensity of their pain. A mechanism-based approach to oncologic pain therapy is critical to ensure that analgesia regimens are individualized and effective. Since the mechanisms that lead to cancer pain are complex, healthcare providers must be willing to elicit and recognize the symptoms of each individual patient since these factors influence both the experience of pain and response to treatment. This process is centered on the use of detailed history in order to understand symptom expression in the context of primary tumor diagnosis and progression, history of cancer pain, psychological distress, sleep disturbances, cognitive function, and addictive behavior. Incorporating all of these factors into the assessment of a patient's pain condition can facilitate management decisions and help predict patient response to treatment.
| Media Type: |
Electronic Article |
|---|
| Year of Publication: |
2020 |
|---|
| Contained In: |
Oncology and therapy - Vol. 8, No. 2 (2020), p. 251-259 |
|---|
| Language: |
English |
|---|
| Contributors: |
Gress, Kyle L |
|---|
| Links: |
|---|
| Keywords: |
Cancer pain |
|---|
| Notes: |
Date Revised 01.12.2020 published: Print-Electronic Citation Status PubMed-not-MEDLINE Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine |
|---|
| Physical Description: |
Online-Ressource |
|---|
| doi: |
10.1007/s40487-020-00128-y |
|---|---|
| PMID: |
32894414 |
| PPN (Catalogue-ID): |
NLM315618973 |
|---|
| LEADER | 02654nma a2200541 c 4500 | ||
|---|---|---|---|
| 001 | NLM315618973 | ||
| 003 | DE-601 | ||
| 005 | 20201201214725.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200907s2020 000 0 eng d | ||
| 024 | 7 | |a 10.1007/s40487-020-00128-y |2 doi | |
| 028 | 5 | 2 | |a pubmed20n1484.xml |
| 035 | |a (DE-599)NLM32894414 | ||
| 040 | |b ger |c GBVCP | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Gress, Kyle L | |
| 245 | 1 | 3 | |a An Overview of Current Recommendations and Options for the Management of Cancer Pain |h Elektronische Ressource |b A Comprehensive Review |
| 300 | |a Online-Ressource | ||
| 500 | |a Date Revised 01.12.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 500 | |a Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine | ||
| 520 | |a It is estimated that one-third of oncologic patients in the USA do not receive analgesia proportional to or adequate for the intensity of their pain. A mechanism-based approach to oncologic pain therapy is critical to ensure that analgesia regimens are individualized and effective. Since the mechanisms that lead to cancer pain are complex, healthcare providers must be willing to elicit and recognize the symptoms of each individual patient since these factors influence both the experience of pain and response to treatment. This process is centered on the use of detailed history in order to understand symptom expression in the context of primary tumor diagnosis and progression, history of cancer pain, psychological distress, sleep disturbances, cognitive function, and addictive behavior. Incorporating all of these factors into the assessment of a patient's pain condition can facilitate management decisions and help predict patient response to treatment | ||
| 611 | 2 | 7 | |a Journal Article |2 gnd |
| 611 | 2 | 7 | |a Review |2 gnd |
| 655 | 7 | |a Cancer pain |2 gnd | |
| 655 | 7 | |a Chronic pain |2 gnd | |
| 655 | 7 | |a Neoplasms |2 gnd | |
| 655 | 7 | |a Opioids |2 gnd | |
| 655 | 7 | |a Pain management |2 gnd | |
| 689 | 0 | 0 | |A f |a Journal Article |
| 689 | 0 | 1 | |A f |a Review |
| 689 | 0 | |5 DE-601 | |
| 689 | 1 | 0 | |a Cancer pain |
| 689 | 1 | 1 | |a Chronic pain |
| 689 | 1 | 2 | |a Neoplasms |
| 689 | 1 | 3 | |a Opioids |
| 689 | 1 | 4 | |a Pain management |
| 689 | 1 | |5 DE-601 | |
| 700 | 1 | |a Charipova, Karina | |
| 700 | 1 | |a Kaye, Alan D | |
| 700 | 1 | |a Viswanath, Omar | |
| 700 | 1 | |a Urits, Ivan | |
| 773 | 0 | 8 | |i in |t Oncology and therapy |g Vol. 8, No. 2 (2020), p. 251-259 |q 8:2<251-259 |w (DE-601)NLM26964489X |x 2366-1089 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1007/s40487-020-00128-y |3 Volltext |
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2020 |e 2 |b 07 |c 12 |h 251-259 | ||